NOCIL
- P/E
- 34.60
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 3.93%
- Debt to Equity
- 0.00
- EPS (TTM)
- ₹3.96
- Book Value
- ₹108.14
- Market Cap
- —
- P/E (TTM)
- 34.60
- P/B
- 1.27
- ROE
- 2.60%
- Dividend Yield
- 1.10%
- EBITDA
- ₹138 Cr
- 52W High
- ₹211.20
- 52W Low
- ₹125.31
- Volume
- 0
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| ₹137.02 | 34.60 | ₹2,225 Cr | 1.27 | 1.10% | 2.60% | 3.93% | ₹1,370 Cr | ₹66 Cr | |
| Median 8 companies | ₹1,559.55 | 45.82 | ₹20,474 Cr | 4.68 | 0.36% | 9.74% | 11.65% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 55
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 43
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 29
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 81
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 16
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 38.4%
Weaknesses
3- The company has delivered a poor sales growth of 7.10% over past five years.
- Promoter holding is low: 33.8%
- Company has a low return on equity of 4.98% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 2 | 5 |
| Oscillators | Strong Bullish | 2 | 2 | 5 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Strong Bullish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 29.28
- Bullish
- MACD (12,26,9)
- −9.46
- Bearish
- SMA (50)
- 168.46
- Bearish
- SMA (200)
- 162.29
- Bearish
As of
Analyst Rating
2 of 4 analysts rate Buy, 2 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +6.19% |
|---|---|
| 5Y | +7.09% |
| 3Y | −6.94% |
| 1Y | −6.46% |
| TTM | +0.96% |
Net profit
| 10Y | −3.26% |
|---|---|
| 5Y | −8.64% |
| 3Y | −27.83% |
| 1Y | −45.63% |
| TTM | −29.03% |
Operating cash flow
| 10Y | +4.01% |
|---|---|
| 5Y | +21.80% |
| 3Y | −3.68% |
| 1Y | +869.23% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −11.83 pp |
|---|---|
| 5Y | −6.52 pp |
| 3Y | −7.90 pp |
| 1Y | −2.08 pp |
| TTM | −0.97 pp |
Revenue by year
| Mar 2017 | ₹742 Cr |
|---|---|
| Mar 2018 | ₹964 Cr |
| Mar 2019 | ₹1,043 Cr |
| Mar 2020 | ₹846 Cr |
| Mar 2021 | ₹925 Cr |
| Mar 2022 | ₹1,571 Cr |
| Mar 2023 | ₹1,617 Cr |
| Mar 2024 | ₹1,445 Cr |
| Mar 2025 | ₹1,393 Cr |
| Mar 2026 | ₹1,303 Cr |
Net profit by year
| Mar 2017 | ₹97.00 Cr |
|---|---|
| Mar 2018 | ₹170 Cr |
| Mar 2019 | ₹185 Cr |
| Mar 2020 | ₹131 Cr |
| Mar 2021 | ₹88.00 Cr |
| Mar 2022 | ₹176 Cr |
| Mar 2023 | ₹149 Cr |
| Mar 2024 | ₹133 Cr |
| Mar 2025 | ₹103 Cr |
| Mar 2026 | ₹56.00 Cr |
Analyst Forecasts
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 397 | 351 | 341 | 356 | 372 | 363 | 318 | 340 | 336 | 321 | 316 | 330 | 403 | 427 |
| Expenses | 341 | 306 | 292 | 312 | 331 | 325 | 294 | 305 | 306 | 298 | 289 | 309 | 358 | 391 |
| Operating Profit | 56 | 45 | 49 | 45 | 41 | 38 | 24 | 34 | 31 | 22 | 27 | 21 | 45 | 36 |
| OPM % | 14% | 13% | 14% | 13% | 11% | 10% | 8% | 10% | 9% | 7% | 8% | 6% | 11% | 8% |
| Other Income | 5 | 5 | 6 | 25 | 9 | 8 | 9 | 6 | 7 | 10 | 1 | 14 | 6 | 7 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 13 | 13 | 13 | 13 | 13 | 13 | 14 | 13 | 14 | 14 | 14 | 14 | 14 | 14 |
| PBT | 47 | 37 | 41 | 56 | 37 | 32 | 19 | 26 | 23 | 19 | 13 | 21 | 37 | 28 |
| Tax % | 27% | 26% | 26% | 25% | 26% | −30% | 32% | 20% | 25% | 35% | 31% | 19% | 25% | 15% |
| Net Profit | 34 | 27 | 30 | 42 | 27 | 42 | 13 | 21 | 17 | 12 | 9 | 17 | 28 | 24 |
| EPS (₹) | 2.06 | 1.63 | 1.8 | 2.49 | 1.62 | 2.52 | 0.77 | 1.24 | 1.03 | 0.73 | 0.55 | 1.02 | 1.66 | — |
Sep 2026: from the results filed on 29 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 719 | 715 | 742 | 964 | 1,043 | 846 | 925 | 1,571 | 1,617 | 1,445 | 1,393 | 1,303 | 1,370 |
| Expenses | 605 | 575 | 582 | 695 | 750 | 668 | 793 | 1,284 | 1,364 | 1,250 | 1,255 | 1,202 | 1,254 |
| Operating Profit | 114 | 140 | 160 | 269 | 293 | 178 | 132 | 288 | 253 | 195 | 137 | 101 | 115 |
| OPM % | 16% | 20% | 22% | 28% | 28% | 21% | 14% | 18% | 16% | 14% | 10% | 8% | 8% |
| Other Income | 3 | 3 | 9 | 11 | 10 | 9 | 14 | 2 | 6 | 39 | 32 | 31 | 31 |
| Interest | 17 | 9 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 |
| Depreciation | 14 | 15 | 20 | 24 | 24 | 34 | 37 | 48 | 56 | 53 | 54 | 55 | 55 |
| PBT | 86 | 119 | 147 | 255 | 278 | 152 | 107 | 241 | 202 | 180 | 114 | 76 | 90 |
| Tax % | 34% | 34% | 34% | 33% | 33% | 14% | 17% | 27% | 26% | 26% | 10% | 27% | — |
| Net Profit | 57 | 78 | 97 | 170 | 185 | 131 | 88 | 176 | 149 | 133 | 103 | 56 | 66 |
| EPS (₹) | 3.55 | 4.87 | 5.94 | 10.33 | 11.17 | 7.89 | 5.32 | 10.57 | 8.95 | 7.98 | 6.16 | 3.33 | 3.96 |
| Div. Payout % | 28% | 25% | 30% | 24% | 22% | 32% | 38% | 28% | 34% | 38% | 32% | 45% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 161 | 161 | 164 | 164 | 165 | 166 | 166 | 167 | 167 | 167 | 167 | 167 |
| Reserves | 254 | 309 | 750 | 882 | 998 | 1,020 | 1,119 | 1,279 | 1,385 | 1,532 | 1,595 | 1,606 |
| Borrowings | 147 | 26 | 15 | 5 | 0 | 7 | 6 | 6 | 10 | 13 | 10 | 8 |
| Other Liabilities | 193 | 186 | 233 | 279 | 279 | 250 | 324 | 380 | 295 | 304 | 284 | 329 |
| Total Liabilities | 755 | 682 | 1,161 | 1,331 | 1,442 | 1,442 | 1,615 | 1,830 | 1,857 | 2,015 | 2,057 | 2,111 |
| Fixed Assets | 311 | 307 | 543 | 528 | 657 | 797 | 918 | 909 | 888 | 870 | 855 | 831 |
| CWIP | 3 | 6 | 4 | 42 | 131 | 156 | 14 | 8 | 9 | 16 | 60 | 221 |
| Investments | 22 | 22 | 176 | 281 | 130 | 54 | 68 | 53 | 218 | 399 | 366 | 415 |
| Other Assets | 418 | 347 | 438 | 480 | 524 | 434 | 614 | 859 | 742 | 730 | 776 | 645 |
| Total Assets | 755 | 682 | 1,161 | 1,331 | 1,442 | 1,442 | 1,615 | 1,830 | 1,857 | 2,015 | 2,057 | 2,111 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 30 | 170 | 142 | 102 | 164 | 179 | 94 | −30 | 282 | 201 | 26 | 252 |
| Investing | −5 | −12 | −11 | −141 | −101 | −106 | −58 | 31 | −217 | −77 | −37 | −212 |
| Financing | −33 | −151 | −31 | −43 | −50 | −101 | 0 | −34 | −54 | −55 | −50 | −38 |
| Net Cash Flow | −8 | 8 | 101 | −82 | 13 | −28 | 35 | −33 | 11 | 68 | −62 | 2 |
| Free Cash Flow | 21 | 156 | 129 | 55 | −73 | 0 | 67 | −66 | 253 | 184 | −95 | 84 |
| CFO/EBITDA | 43 | 144 | 117 | 68 | 86 | 129 | 71 | 10 | 131 | 124 | 44 | 274 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 85 | 77 | 82 | 92 | 81 | 88 | 122 | 104 | 78 | 86 | 81 | 81 |
| Inventory Days | 176 | 135 | 116 | 129 | 133 | 128 | 120 | 141 | 117 | 100 | 129 | 75 |
| Days Payable | 79 | 74 | 82 | 96 | 77 | 84 | 123 | 91 | 52 | 53 | 54 | 72 |
| Cash Conversion Cycle | 182 | 138 | 116 | 125 | 138 | 132 | 119 | 154 | 143 | 133 | 156 | 84 |
| Working Capital Days | 71 | 86 | 86 | 94 | 99 | 104 | 114 | 128 | 108 | 110 | 130 | 91 |
| ROCE % | 19% | 24% | 21% | 26% | 25% | 13% | 9% | 18% | 13% | 10% | 6% | 4% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view NOCIL insights
65 extracted metrics across FY08–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT
- Q3 FY26 concall · Feb 2026Transcript PPT
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- Q1 FY26 concall · Aug 2025Transcript PPT
- 14 Oct 2025
- 3 Oct 2025
- 16 Jan 2025
- 26 Dec 2024
- 30 Oct 2023
- General announcements 30 Oct 2026
- General announcements 16 Oct 2026
Frequently Asked Questions about NOCIL
What does NOCIL Ltd do?
Where is NOCIL Ltd (NOCIL) listed?
Which sector does NOCIL Ltd belong to?
What is the PE ratio of NOCIL Ltd?
What is the 52-week high and low of NOCIL Ltd?
Does NOCIL Ltd pay dividends?
What is the Return on Equity (ROE) of NOCIL Ltd?
Company Information
NOCIL Ltd., incorporated in 1961, manufactures rubber chemicals which are used by the tyre industry and other rubber processing industries. It is a part of Arvind Mafatlal Group and is the Largest Rubber Chemicals Manufacturer in India.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NOCIL.md for NOCIL Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.